Tag Archives: India approves antiviral drug to treat COVID-19 patients

BENGALURU: India’s government said on Tuesday it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use in treating COVID-19 patients. Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials. It was granted emergency use authorization by the U.S. Food and Drug Administration last month and has received approval by Japanese health regulators. …

Read More »